Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Struewing

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|June 12, 2003
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israelG Hirsh-Yechezkel, A Chetrit, F Lubin, et al.
American Journal of Medical Genetics|August 18, 2000
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer familiesB B Biesecker, N Ishibe, D W Hadley, et al.
Maryland Medical Journal (Baltimore, Md. : 1985)|June 1, 1989
Predictors of rehabilitation outcome among patients with SCIR S Epstein, A Lefkowitz, C M Sharkness, et al.
Lancet (London, England)|November 5, 1998
Population-based study of risk of breast cancer in carriers of BRCA2 mutationS Thorlacius, J P Struewing, P Hartge, et al.
Genetic Testing|January 1, 1997
Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assayM R Abbaszadegan, J P Struewing, K M Brown, et al.
Journal of the National Cancer Institute|February 26, 1999
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersJ S Lee, S Wacholder, J P Struewing, et al.
Gynecologic Oncology|December 31, 2002
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish womenJ Menczer, A Chetrit, G Barda, et al.
The New England Journal of Medicine|May 15, 1997
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsJ P Struewing, P Hartge, S Wacholder, et al.
Journal of Medical Genetics|June 1, 2005
Skewed X chromosome inactivation and early-onset breast cancerJ P Struewing, M A Pineda, M E Sherman, et al.
British Journal of Cancer|January 22, 2004
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma riskA Baccarelli, D Calista, P Minghetti, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|June 12, 2003
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israelG Hirsh-Yechezkel, A Chetrit, F Lubin, et al.
American Journal of Medical Genetics|August 18, 2000
Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer familiesB B Biesecker, N Ishibe, D W Hadley, et al.
Maryland Medical Journal (Baltimore, Md. : 1985)|June 1, 1989
Predictors of rehabilitation outcome among patients with SCIR S Epstein, A Lefkowitz, C M Sharkness, et al.
Lancet (London, England)|November 5, 1998
Population-based study of risk of breast cancer in carriers of BRCA2 mutationS Thorlacius, J P Struewing, P Hartge, et al.
Genetic Testing|January 1, 1997
Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assayM R Abbaszadegan, J P Struewing, K M Brown, et al.
Journal of the National Cancer Institute|February 26, 1999
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersJ S Lee, S Wacholder, J P Struewing, et al.
Gynecologic Oncology|December 31, 2002
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish womenJ Menczer, A Chetrit, G Barda, et al.
The New England Journal of Medicine|May 15, 1997
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsJ P Struewing, P Hartge, S Wacholder, et al.
Journal of Medical Genetics|June 1, 2005
Skewed X chromosome inactivation and early-onset breast cancerJ P Struewing, M A Pineda, M E Sherman, et al.
British Journal of Cancer|January 22, 2004
XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma riskA Baccarelli, D Calista, P Minghetti, et al.
Pageof 5